Emerging Trends to Drive Personalized Medicine Market Growth at 11.4% CAGR Through 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Personalized Medicine Market Size Growth Forecast: What to Expect by 2025?
There has been significant growth in the personalized medicine market size in the past few years. The market is projected to expand from a size of $386.27 billion in 2024 to $422.9 billion in 2025, representing a compound annual growth rate (CAGR) of 9.5%. The notable growth during this period is largely due to factors such as the emergence of companion diagnostics, a shift towards patient-centric healthcare, changes in drug development paradigms, endeavors to manage healthcare costs, and an increasing occurrence of chronic diseases.

How Will the Personalized Medicine Market Size Evolve and Grow by 2029?
Swift expansion is expected in the personalized medicine market size over the coming years. By 2029, the market is tipped to expand to a whopping $650.59 billion, seeing a compound annual growth rate (CAGR) of 11.4%. Such growth during the forecast period can be linked to the ongoing advancements in genomics, the rise in biomarker discovery, tech-enabled healthcare via telemedicine, supportive regulatory environments, and collaboration and data sharing. Key trends observed during the forecast period comprise the integration of artificial intelligence (AI), innovations in genomic sequencing, data consolidation and analysis, targeted therapies and immunotherapy, empowered patients making informed decisions, as well as collaborations and partnerships.

View the full report here:
https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report

What Drivers Are Propelling the Growth of Personalized Medicine Market Forward?
The growth of the personalized medicine market is anticipated to be spurred by the increasing prevalence of rare diseases. This refers to the escalating count of people being diagnosed with conditions like Klinefelter Syndrome, Aarskog Syndrome, and Abetalipoproteinemia. Customized medication provides bespoke solutions, catering to the specific needs of patients suffering from unique disorders. For example, as per the Genetic Alliance UK, an organization focused on supporting individuals impacted by genetic, rare, and undiagnosed diseases, there are 3.5 million people living with a rare condition in the UK as of February 2024. Moreover, 1 in 17 people will have a rare illness at some point in their lives. As such, as the number of rare condition cases continues to increase, it concurrently stimulates the growth of the personalized medicine market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10272&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Personalized Medicine Market?
The pervasiveness of technological innovations is a crucial trend escalating in the domain of personalized medicine. Leading organizations in the personalized medicine market are integrating new technologies to maintain their market dominance. For example, in April 2023, OM1, an American healthcare firm using real-world data and artificial intelligence (AI) to support healthcare practitioners, secured a patent for an AI-driven platform to accelerate personalized medicine. This technology leverages large-scale data analysis to produce significant insights into diagnostics, disease progression, and responses to treatment. It plays a critical role by providing bespoke healthcare recommendations, increasing knowledgeable decision-making for healthcare providers, and speeding up clinical trials by efficiently identifying suitable candidates, significantly aiding the progression of personalized medicine in the market.

What Are the Key Segments in the Personalized Medicine Market?
The personalized medicine market covered in this report is segmented -

1) By Product: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness
2) By Application: Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications
3) By End-use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-Users

Subsegments:
1) By Personalized Medicine Diagnostics: Genetic Testing, Biomarker Testing, Companion Diagnostics, Molecular Imaging
2) By Personalized Medicine Therapeutics: Targeted Therapies, Gene Therapies, Monoclonal Antibodies, Cell and Gene Therapy Products
3) By Personalized Medical Care: Tailored Treatment Plans, Patient-Centric Care Models, Digital Health Solutions, Remote Patient Monitoring
4) By Personalized Nutrition And Wellness: Nutrigenomics, Customized Diet Plans, Supplement Personalization, Lifestyle Modification Programs

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10272&type=smp

Who Are the Key Players Shaping the Personalized Medicine Market's Competitive Landscape?
Major companies operating in the personalized medicine market include Bayer AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, AstraZeneca plc, Abbott Laboratories, Danaher Corporation, Eli Lilly and Company, Decode Genetics Inc., GE HealthCare Technologies Inc., Roche Diagnostics, Genentech Inc., Biogen Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Myriad Genetics Inc., Verily Life Sciences LLC, Guardant Health Inc., Tempus Labs, Oxford Nanopore Technologies, Foundation Medicine Inc., NanoString Technologies Inc., Exagen Inc., Asuragen Inc., Personal Genome Diagnostics, Precision Biologics Inc., Strata Oncology, Genelex Corp, Invitae Corporation, Color Genomics, Helix OpCo LLC, 10x Genomics Inc., Agena Bioscience Inc., Natera Inc., Becton Dickinson and Company, PerkinElmer Inc., Sophia Genetics, Genomic Vision, Personalis Inc.

What Geographic Markets Are Powering Growth in the Personalized Medicine Market?
North America was the largest region in the personalized medicine market in 2024. Asia-pacific is expected to be the fastest-growing region in the global personalized medicine market during the forecast period. The regions covered in the personalized medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10272

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.